Projected benefits from integrating NTD programs in sub-Saharan Africa

Trends in Parasitology

Volumn 22, Issue 7, 2006, Pages 285-291

  Brady, Molly A ^a   Hooper, Pamela J ^a   Ottesen, Eric A ^a  

^a Lymphatic Filariasis Support Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EMPIRICISM; FILARIASIS; HELMINTHIASIS; HUMAN; SCHISTOSOMIASIS; TRACHOMA; TROPICAL DISEASE;

AFRICA SOUTH OF THE SAHARA; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; COST-BENEFIT ANALYSIS; HELMINTHIASIS; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION; TRACHOMA; TROPICAL MEDICINE;

EID: 33745338025     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2006.05.007     Document Type: Article

References (43)

1. Molyneux, D.H. et al. (2005) 'Rapid-impact interventions': how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 10.1371/journal.pmed.0020336 (http://www.plosmedicine.org)
2. Horton J., et al. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 121 (2000) S147-S160
3. Olds G.R., et al. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J. Infect. Dis. 179 (1999) 996-1003
4. Na-Bangchang K., et al. Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel, and ivermectin combinations. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 335-345
5. Fenwick A., et al. Achieving the Millennium Development Goals. Lancet 365 (2005) 1029-1030
6. WHO (2005) Deworming for health and development: Report of the Third Annual Meeting of the Partners for Parasite Control. WHO/CDS/CPE/PVC/2005.14 (http://www.who.int)
7. WHO. Global programme to eliminate lymphatic filariasis: progress report for 2004. Wkly Epidemiol. Rec. 80 (2005) 202-212
8. Thylefors B. Eliminating onchocerciasis as a public health problem. Trop. Med. Int. Health 9 (2004) A1-A3
9. de Silva N.R., et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 19 (2003) 547-551
10. Chitsulo L., et al. The global status of schistosomiasis and its control. Acta Trop. 77 (2000) 41-51
11. Kumaresan J., and Mecaskey J.W. The global elimination of blinding trachoma: progress and promise. Am. J. Trop. Med. Hyg. 69 (2003) 24-28
12. Engels D., and Savioli L. Public health strategies for schistosomiasis control. In: Secor W.E., and Colley D.G. (Eds). World Class Parasites Vol. 10: Schistosomiasis (2005), Springer 207-222
13. McFarland, D.A. and Menzies, N. Cost per treatment with ivermectin using the CDTI strategy: Final Report. African Programme for Onchocerciasis Control (APOC) (in press)
14. de Rochars M., et al. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am. J. Trop. Med. Hyg. 71 (2004) 466-470
15. Ottesen E.A., and Campbell W.C. Ivermectin in human medicine. J. Antimicrob. Chemother. 34 (1994) 195-203
16. Ottesen E.A. Filariasis. In: Cohen J., and Powderly W.G. (Eds). Infectious Diseases. 2nd edn (2004), Elsevier 1607-1613
17. Tielsch J.M., and Beeche A. Impact of ivermectin on illness and disability associated with onchocerciasis. Trop. Med. Int. Health 9 (2004) A45-A56
18. Little M.P., et al. Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet 363 (2004) 1514-1521
19. WHO (2002) The World Health Report 2002, 192-197 (http://www.who.int)
20. WHO Expert Committee. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. WHO Tech. Rep. Ser. 912 (2002) 1-57
21. Hotez, P.J. et al. (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 10.1371/journal.pmed.0030102 (http://www.plosmedicine.org)
22. Okeibunor J.C., et al. Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control. Trop. Med. Int. Health 9 (2004) 887-896
23. Guyatt H.L., et al. Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania. Bull. WHO 79 (2001) 695-703
24. Baltussen R.M.P.M., et al. Cost-effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol. 12 (2005) 91-101
25. Waters H.R., et al. Economic evaluation of Mectizan distribution. Trop. Med. Int. Health 9 (2004) A16-A25
26. Shi Z., et al. Cost-benefit analysis on Malayan filariasis control in Miaoxi Township, Huzhou City, Zhejiang Province during 1964-1987. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 13 (1995) 193-196
27. Ottesen E.A. Lymphatic filariasis: Treatment, control, and elimination. Adv. Parasitol. 61 (2006) 395-441
28. Boatin B.A., and Richards Jr. F.O. Control of onchocerciasis. Adv. Parasitol. 61 (2006) 349-394
29. Fenwick A., et al. Implementation of human schistosomiasis control: challenges and prospects. Adv. Parasitol. 61 (2006) 567-622
30. Albonico M., et al. Interventions for the control of soil-transmitted helminthiasis in the community. Adv. Parasitol. 61 (2006) 311-348
31. Mecaskey J.W., et al. The possibility of eliminating blinding trachoma. Lancet Infect. Dis. 3 (2003) 728-734
32. Zagaria N., and Savioli L. Elimination of lymphatic filariasis: a public health challenge. Ann. Trop. Med. Parasitol. 96 (2002) S3-S13
33. Gyapong J.O., et al. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin. Pharmacother. 6 (2005) 179-200
34. Burnham G., and Mebrahtu T. Delivery of ivermectin. Trop. Med. Int. Health 9 (2004) A26-A44
35. WHO (2005) Deworming: The Millennium Development Goals. WHO/CDS/CPE/PVC/2005.12. (http://www.who.int)
36. Global Alliance to Eliminate Lymphatic Filariasis (2004) LF News 5, 1-6 (http://www.filariasis.org)
37. Michael E., et al. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112 (1996) 409-428
38. WHO (1998) Report of the WHO Informal Consultation on Hookworm Infection and Anaemia in Girls and Women. WHO/CTD/SIP/96.1 (http://www.who.int)
39. Resnikoff S., et al. Global data on visual impairment in the year 2002. Bull. WHO 82 (2004) 844-851
40. Thylefors B., et al. Trachoma-related visual loss. In: Murray C.J.L., and Lopez A. (Eds). The Global Epidemiology of Infectious Diseases (2004), Harvard University Press 301-324
41. Remme, J.H. (2004) The global burden of onchocerciasis in 1990. World Health Organization (==http://www3.who.int/whosis/menu.cfm?path=evidence,burden,burden_gbd2000docs,burden_gbd2000docs_diseasedoc,burden_gbd2000docs_diseasedoc_oncho&language=english)
42. WHO Expert Committee. Onchocerciasis and its control. Report of a WHO expert committee on onchocerciasis control. WHO Tech. Rep. Ser. 852 (1995) 1-104
43. van der Werf M.J., et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86 (2003) 125-139